Comparison Results | RestoredCDC.org

Comparison timestamp: 2025-05-07 02:14:40 UTC
RestoredCDC URL: http://restoredcdc.org/www.cdc.gov/coca/hcp/trainings/resurgence-new-world-screwworm.html
Live cdc.gov URL ↗: https://www.cdc.gov/coca/hcp/trainings/resurgence-new-world-screwworm.html
Removed: Line removed from cdc.gov. Specific word removals are highlighted.
Added: Line added to cdc.gov. Specific word additions are highlighted.
Injected: Line or disclaimer added by RestoredCDC.org.
Unchanged: Line unchanged.
Enable word-level highlighting (experimental)? High contrast mode
    Original site: www.cdc.gov/coca/hcp/trainings/resurgence-new-world-screwworm.html | RestoredCDC.org is an independent project, not affiliated with CDC or any federal entity. Visit CDC.gov for free official information. Due to archival on January 6, 2025, recent outbreak data is unavailable. Videos are not restored. Access data.restoredcdc.org for restored data. Use of this site implies acceptance of this disclaimer.
    [More]
    About Us Report Bug Compare Content
  Skip directly to site content Skip directly to search Skip directly to On This Page
          An official website of the United States government
        Here's how you know
              Official websites use .gov
              A .gov website belongs to an official government organization in the United States.
              Secure .gov websites use HTTPS
              A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.
        Clinician Outreach and Communication Activity (COCA)
          Explore Topics
        Search
          Search
          Clear Input
        Health Care Providers
          * About
          * COCA Calls
          * COCA Resources
          * View all
        View All
      search close search
          search
    COCA Menu Close
    COCA Menu
          search
              Health Care Providers
                  * About
                  * COCA Calls
                  * COCA Resources
                  * View All
        View All COCA
    About COCA Calls COCA Resources View All
October 17, 2024
  Resurgence of New World Screwworm in the Americas: What Healthcare Providers Need to Know
          At a glance
          During this COCA Call, a subject matter expert will outline the biology and life cycle of C. hominivorax, explain the current epidemiology in Central America, review guidance on how to identify infestations, and discuss how to appropriately manage and report cases of NWS in humans.
        Webinar
              Resurgence of New World Screwworm in the Americas: Update for Clinicians
        View Slides
        Transcript
        Free Continuing Education
        Overview
        New World screwworm (NWS) (Cochliomyia hominivorax) flies produce larvae that feed on living tissue, causing disease primarily in animals and livestock, though humans can also be infested. NWS was eradicated in the United States in the 1960s, in Mexico in the 1970s, and in Central America in the early 2000s. However, Panama, Costa Rica, Nicaragua, and Honduras have recently documented new cases, causing concern about continued northward spread. In addition, travel-associated cases are occasionally identified in people returning to the United States from areas where NWS is endemic, posing an ongoing threat of re-introduction to the United States. Raising awareness of NWS among healthcare providers will improve rapid diagnosis, appropriate management, and critical reporting to appropriate entities.
        During this COCA Call, a subject matter expert will outline the biology and life cycle of C. hominivorax, explain the current epidemiology in Central America, review guidance on how to identify infestations, and discuss how to appropriately manage and report cases of NWS in humans.
        Presenters
        Rebecca Chancey, MD
        Medical Officer
        Division of Parasitic Diseases and Malaria
        National Center for Emerging and Zoonotic Infectious Diseases
        Centers for Disease Control and Prevention
        Mark Fox, MS, MS (Q & A Only)
        Biologist
        Division of Parasitic Diseases and Malaria
        National Center for Emerging and Zoonotic Infectious Diseases
        Centers for Disease Control and Prevention
        Susan P. Montgomery, DVM, MPH (Q & A Only)
        Team Lead
        Division of Parasitic Diseases and Malaria
        National Center for Emerging and Zoonotic Infectious Diseases
        Centers for Disease Control and Prevention
        Call Objectives
        COCA Call Objectives
        At the conclusion of the session, the participant will be able to accomplish the following:
         1. Cite background information on the topic covered during the presentation.
         2. Discuss CDC's role in the topic covered during the presentation.
         3. Describe the topic's implications for clinicians.
         4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
         5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.
        Activity-Specific Objectives
         1. Explain the life cycle of Cochliomyia hominivorax and why the larvae are a threat to animal and human health.
         2. Describe the current epidemiological situation in Central America.
         3. Summarize how to identify and treat infestations.
         4. Outline how to report human and animal cases.
        Additional Resources
        NWS – CDC
          * About New World Screwworm Myiasis | Myiasis | CDC
          * Clinical Overview of New World Screwworm Myiasis | Myiasis | CDC
          * Acerca de la miasis por el gusano barrenador del Nuevo Mundo | Myiasis | CDC
          * Información clínica sobre la miasis por el gusano barrenador del Nuevo Mundo | Myiasis | CDC
          * Laboratory Diagnosis of New World Screwworm (bench aid)
        NWS – external resources
          * New World screwworm – USDA
          * New World screwworm: What You Need to Know (English and Spanish)
          * New World screwworm Story Map
          * Screwworm: An International Threat to Human and Animal Health
        Reporting agencies
          * Human cases – local and state health departments
          * Animal cases – state animal health office and APHIS office
        Insect bite prevention – CDC
          * Preventing Mosquito Bites | Mosquitoes | CDC
          * Preventing Mosquito Bites While Traveling | Mosquitoes | CDC
          * About Permethrin-Treated Clothing and Gear | Mosquitoes | CDC
          * How to Prevent Mosquito and Tick Bites | Vector-Borne Diseases | CDC
        Insect repellents
          * EPA-registered insect repellent
        Clinical or diagnostic assistance
          * Clinical inquiries and case management questions from healthcare providers and health departments is available from CDC at 404-718-4745 or parasites@cdc.gov (during regular business hours).
          * Direct inquiries outside of regular business hours to CDC's Emergency Operations Center at 770-488-7100.
          * Diagnostic assistance for suspected human cases – dpdx@cdc.gov.
        Continuing Education
        Instructions for Obtaining Continuing Education (CE)
        To receive continuing education (CE) for WC4520R-101724—Resurgence of New World Screwworm in the Americas: What Healthcare Providers Need to Know, please visit CDC TRAIN and search for the course in the Course Catalog using WC4520R-101724. Follow the steps below by November 18, 2024. The registration code is COCA101724.
        To receive continuing education (CE) for WD4520R-101724— Resurgence of New World Screwworm in the Americas: What Healthcare Providers Need to Know, please visit CDC TRAIN and search for the course in the Course Catalog using WD4520R-101724. Follow the steps below between November 19, 2024, and November 19, 2026.
         1. Register for and complete the course.
         2. Pass the post-assessment at 75%.
         3. Complete the evaluation.
         4. Visit Your Learning to access your certificates and transcript.
        Accreditation Statements
        In support of improving patient care, The Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
          CDC is a Jointly Accredited Provider of Interprofessional Continuing Education.
        CME: The Centers for Disease Control and Prevention designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
        AAPA CME: Credit Designation Statement – Live
        The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
        CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.
        CPE: The Centers for Disease Control and Prevention designated this Knowledge-based event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-23-147-L04-P and enduring is JA4008229-0000-23-148-H04-P.
        CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEUs for this program.
        CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.
        AAVSB/RACE: This program has been submitted (but not yet approved) for 1 hours of continuing education credit in jurisdictions which recognize AAVSB RACE approval; however, participants should be aware that some boards have limitations on the number of hours accepted in certain categories or restrictions on certain methods of delivery of continuing education.
        For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
        DISCLOSURE: In compliance with continuing education requirements, all planners and presenters/moderators must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
        CDC, our planners, presenters, and moderators wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
        Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Rebecca Chancey's discussion of anecdotal reports of using ivermectin in off-label treatment of NWS infestations in humans. However, there are no controlled, double-blind studies measuring the impact of ivermectin use on myasis. At this time, it is not a CDC recommended treatment for NWS. In addition, Mark Fox and Dr. Susan Montgomery who will be participating in the Q & A session, will also discuss this, if requested.
        CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
        Target Audience
          * Physicians
          * Nurses
          * Pharmacists
          * Veterinarians
          * Physician Assistants
          * Health Educators
          * Other Clinicians
        Additional Information
          * Contact Information: coca@cdc.gov
          * Support/Funding: Centers for Disease Control and Prevention, Office of Emergency Risk Communication
          * Method of Participation: You may participate in the educational activity by viewing the program information above.
        On This Page
            * Webinar
            * Overview
            * Presenters
            * Call Objectives
            * Additional Resources
            * Continuing Education
            * Target Audience
            * Additional Information
          Related PagesCOCA Calls
          Related Pages
        * 
 
        * What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19
            * COCA Calls
        * 
            * Updated Recommendations for COVID-19 Vaccine Use
            * Evaluating and Supporting Children and Adolescents Presenting with Post-COVID Conditions
            * Updates to COVID-19 Testing and Treatment for the Current SARS-CoV-2 Variants
            * New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease
        * 
            * Murine Typhus
        * View All
          View All COCA
 
    Murine Typhus
        Back to Top
  October 17, 2024
      Sources Print Share
        Facebook LinkedIn Twitter Syndicate
          Content Source:
      Related PagesCOCA Calls
      Related Pages
    * 
 
    * What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19
        * COCA Calls
    * 
        * Updated Recommendations for COVID-19 Vaccine Use
        * Evaluating and Supporting Children and Adolescents Presenting with Post-COVID Conditions
        * Updates to COVID-19 Testing and Treatment for the Current SARS-CoV-2 Variants
        * New Clinical Tools and Resources to Support Patients with Prolonged Symptoms and Concerns about Lyme Disease
    * 
        * Murine Typhus
    * View All
      View All COCA
  Back to Top
    COCA
    COCA prepares clinicians to respond to emerging health threats and public health emergencies by communicating timely information and clinical guidance.
    View All
          * About
          * COCA Calls
          * COCA Resources
        Sign up for Email Updates
    Contact Us
        Contact Us
          * Call 800-232-4636
          * Contact CDC
    About CDC
        About CDC
          * Pressroom
          * Organization
          * Budget & Funding
          * Careers & Jobs
    Policies
              * Accessibility
              * External Links
              * Privacy
              * Web Policies
              * FOIA
              * OIG
              * No Fear Act
              * Nondiscrimination
              * Vulnerability Disclosure Policy
    Languages
            Languages
              * Español
            Language Assistance
                  * Español
                  * 繁體中文
                  * Tiếng Việt
                  * 한국어
                  * Tagalog
                  * Русский
                  * العربية
                  * Kreyòl Ayisyen
                  * Français
                  * Polski
                  * Português
                  * Italiano
                  * Deutsch
                  * 日本語
                  * فارسی
                  * English
    Archive
          * CDC Archive
          * Public Health Publications
    Contact Us
      Contact Us
        * Call 800-232-4636
        * Contact CDC
    About CDC
        * Pressroom
        * Organization
        * Budget & Funding
        * Careers & Jobs
        * About CDC
    Policies
        * Accessibility
        * External Links
        * Privacy
        * Web Policies
        * FOIA
        * OIG
        * No Fear Act
        * Nondiscrimination
        * Vulnerability Disclosure Policy
    Languages
      Languages
        * Español
      Language Assistance
        * Español
        * 繁體中文
        * Tiếng Việt
        * 한국어
        * Tagalog
        * Русский
        * العربية
        * Kreyòl Ayisyen
        * Français
        * Polski
        * Português
        * Italiano
        * Deutsch
        * 日本語
        * فارسی
        * English
    Archive
        * CDC Archive
        * Public Health Publications
    HHS.gov USA.gov
Note: Comparison ignores leading/trailing whitespace and certain script/tracking codes. Word-level highlighting (optional above) only applies to changed lines.